Life expectancy of HIV-positive adults: a review

被引：72

作者：

May, Margaret T. ^{[1
]}

Ingle, Suzanne M. ^{[1
]}

机构：

[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England

来源：

SEXUAL HEALTH | 2011年 / 8卷 / 04期

基金：

英国医学研究理事会;

关键词：

aging; antiretroviral therapy; CD4; immunosuppression; prognosis; sociodemographics; COMBINATION ANTIRETROVIRAL THERAPY; HIGH-INCOME COUNTRIES; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; IMPROVED SURVIVAL; INFECTED PATIENTS; GENERAL-POPULATION; VIRAL SUPPRESSION; SAN-FRANCISCO; UNITED-STATES;

D O I：

10.1071/SH11046

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We review studies estimating life expectancy (LE), the average number of additional years a person can expect to live, for HIV-positive adults and show variation by sociodemographic factors and level of immunosuppression. The LE of patients starting antiretroviral therapy early in the course of HIV infection and attaining restoration of a normal CD4 count may approach that of the general population. Improvements in treatment and the associated increase in LE imply that increasing numbers of HIV-positive patients will live to older age. Late diagnosis and presentation to care and treatment not concordant with guidelines contribute to reducing LE.

引用

页码：526 / 533

页数：8

共 56 条

[1]

Anderson J, 2008, AIDS, V22, P349, DOI 10.1097/QAD.0b013e3282f4709a

[2]

[Anonymous], 2008, WORLD POP PROSP

[3]

Artzrouni M, 2002, AIDS, V16, pW1

[4]

Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4

[5]

Back D, 2010, 10 INT C DRUG THER H

[6] Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations* [J].

Bansi, L. ;

Sabin, C. ;

Delpech, V. ;

Hill, T. ;

Fisher, M. ;

Walsh, J. ;

Chadborn, T. ;

Easterbrook, P. ;

Gilson, R. ;

Johnson, M. ;

Porter, K. ;

Anderson, J. ;

Gompels, M. ;

Leen, C. ;

Ainsworth, J. ;

Orkin, C. ;

Nelson, M. ;

Rice, B. ;

Phillips, A. .

HIV MEDICINE, 2010, 11 (07) :432-438

[7] Changes in the risk of death after HIV seroconversion compared with mortality in the general population [J].

Bhaskaran, Krishnan ;

Hamouda, Osamah ;

Sannes, Mette ;

Boufassa, Faroudy ;

Johnson, Anne M. ;

Lambert, Paul C. ;

Porter, Kholoud .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (01) :51-59

[8] A tale of two futures: HIV and antiretroviral therapy in San Francisco [J].

Blower, SM ;

Gershengorn, HB ;

Grant, RM .

SCIENCE, 2000, 287 (5453) :650-654

[9]

Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2

[10] Gender and the use of antiretroviral treatment in resource-constrained settings: Findings from a multicenter collaboration [J].

Braitstein, Paula ;

Boulle, Andrew ;

Nash, Denis ;

Brinkhof, Martin W. G. ;

Dabis, Francois ;

Laurent, Christian ;

Schechter, Mauro ;

Tuboi, Suely H. ;

Sprinz, Eduardo ;

Miotti, Paolo ;

Hosseinipour, Mina ;

May, Margaret ;

Egger, Matthias ;

Bangsberg, David R. ;

Low, Nicola .

JOURNAL OF WOMENS HEALTH, 2008, 17 (01) :47-55

← 1 2 3 4 5 6 →